STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep prostate cancer from coming back after surgery
Disease control OngoingThis study is for men whose prostate cancer has returned after prostate removal surgery, shown by a rising PSA. It compares standard radiation therapy alone versus radiation plus a drug called apalutamide, which blocks male hormones that fuel cancer growth. The goal is to see if …
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Targeted radiation after prostate surgery shows promise in cancer control
Disease control OngoingThis study looks at whether a special type of radiation called stereotactic body radiotherapy (SBRT) can help prevent prostate cancer from coming back after surgery. About 92 men who had their prostate removed and have signs of remaining cancer will receive SBRT. The goal is to s…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC